Corbus Pharmaceuticals I...

NASDAQ: CRBP · Real-Time Price · USD
7.49
-0.53 (-6.61%)
At close: Jun 27, 2025, 3:59 PM
7.35
-1.87%
After-hours: Jun 27, 2025, 05:55 PM EDT
-6.61%
Bid 7.35
Market Cap 91.65M
Revenue (ttm) n/a
Net Income (ttm) -50.29M
EPS (ttm) -4.24
PE Ratio (ttm) -1.77
Forward PE -1.77
Analyst Buy
Ask 8.7
Volume 147,429
Avg. Volume (20D) 148,919
Open 7.98
Previous Close 8.02
Day's Range 7.49 - 7.98
52-Week Range 4.64 - 61.90
Beta 3.12

About CRBP

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRBP
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CRBP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 month ago
-15.77%
Corbus Pharmaceuticals Holdings shares are trading... Unlock content with Pro Subscription
9 months ago
-62.26%
Corbus Pharmaceuticals Holdings shares are trading lower amid sympathy with Novo Nordisk after the company reported results from its Phase2a trial of Monlunabant in obesity. Also, Wedbush maintained an Outperform rating on the stock but lowered its price target from $85 to $51.